Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy

Front Endocrinol (Lausanne). 2021 Jul 22:12:679655. doi: 10.3389/fendo.2021.679655. eCollection 2021.

Abstract

The global burden of diabetes mellitus and its complications are currently increasing. Diabetic cardiomyopathy (DCM) is the main cause of diabetes mellitus associated morbidity and mortality; therefore, a comprehensive understanding of DCM development is required for more effective treatment. A disorder of epigenetic posttranscriptional modification of histones in chromatin has been reported to be associated with the pathology of DCM. Recent studies have implicated that histone deacetylases could regulate cardiovascular and metabolic diseases in cellular processes including cardiac fibrosis, hypertrophy, oxidative stress and inflammation. Therefore in this review, we summarized the roles of histone deacetylases in the pathogenesis of DCM, aiming to provide insights into exploring potential preventative and therapeutic strategies of DCM.

Keywords: cardiac fibrosis; cardiac hypertrophy; diabetic cardiomyopathy; histone deacetylases; inflammation; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetic Cardiomyopathies / metabolism*
  • Diabetic Cardiomyopathies / pathology
  • Epigenesis, Genetic*
  • Histone Deacetylases / metabolism*
  • Humans
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Oxidative Stress / physiology

Substances

  • Histone Deacetylases